Eliem Therapeutics Future Growth
How is Eliem Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
-14.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | N/A | -83 | -142 | -120 | 3 |
| 12/31/2024 | N/A | -69 | -56 | -61 | 3 |
| 12/31/2023 | N/A | -51 | -46 | -47 | 4 |
| 9/30/2022 | N/A | -48 | -37 | -37 | N/A |
| 6/30/2022 | N/A | -49 | -46 | -46 | N/A |
| 3/31/2022 | N/A | -46 | -40 | -40 | N/A |
| 12/31/2021 | N/A | -52 | -36 | -36 | N/A |
| 9/30/2021 | N/A | -57 | -34 | -34 | N/A |
| 6/30/2021 | N/A | -49 | -23 | -23 | N/A |
| 3/31/2021 | N/A | -40 | -19 | -19 | N/A |
| 12/31/2020 | N/A | -23 | -14 | -14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ELYM is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ELYM is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ELYM is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if ELYM's revenue is forecast to grow faster than the US market.
High Growth Revenue: ELYM is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ELYM's Return on Equity is forecast to be high in 3 years time